From January 1, 2022 to March 31, 2022, the company has repurchased 587,900 shares, representing 0.98% for CNY 20.26 million. With this, the company has completed the repurchase of 587,900 shares, representing 0.98% for CNY 20.26 million under the buyback announced on November 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.26 CNY | +0.68% |
|
+0.49% | -33.14% |
1st Jan change | Capi. | |
---|---|---|
-33.14% | 179M | |
+0.73% | 99.64B | |
-11.98% | 58.77B | |
+75.71% | 48.81B | |
+5.26% | 34.94B | |
+0.61% | 31.15B | |
+3.47% | 18.62B | |
+17.33% | 17.44B | |
+5.92% | 13.51B | |
-6.67% | 12.73B |
- Stock Market
- Equities
- 003017 Stock
- News Zhe Jiang Dayang Biotech Group Co., Ltd.
- Tranche Update on Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback Plan announced on November 26, 2021.